Nephrotic syndrome is a kidney condition that requires carefully managed treatment to control symptoms, prevent serious complications, and protect kidney function over time. Treatment approaches vary depending on the underlying cause, the patient’s age, and how the body responds to initial therapy, making personalized care essential for the best outcomes.

Understanding Treatment Goals for Nephrotic Syndrome

When someone is diagnosed with nephrotic syndrome, the main focus of treatment is to reduce the amount of protein leaking from the kidneys into the urine, control uncomfortable swelling throughout the body, and prevent dangerous complications such as blood clots and infections. Treatment also aims to slow down any progression of kidney damage and improve quality of life so patients can maintain their daily activities, work, and relationships.^[1][2]

The approach to treating nephrotic syndrome depends heavily on what is causing the condition in the first place. In many cases, especially in children, the cause is something called minimal change disease, where the kidney filters appear nearly normal under a microscope but still allow protein to leak through. In adults, other causes such as membranous nephropathy or focal segmental glomerulosclerosis are more common. Sometimes nephrotic syndrome develops as a complication of other health problems like diabetes, lupus, or certain infections.^[3][10]

The treatment plan is built around addressing the specific underlying problem while also managing the symptoms that affect daily life. This means that some patients will respond quickly to treatment and experience remission, while others may need ongoing therapy for months or even years. Medical societies and kidney specialists have developed treatment guidelines based on years of research, but there is also active investigation into new therapies through clinical trials that may offer hope for patients who do not respond to standard treatments.^[8][11]

Standard Treatment Approaches

The backbone of nephrotic syndrome treatment involves several types of medications and lifestyle adjustments that work together to control symptoms and protect the kidneys. These standard treatments are well-established and recommended by medical guidelines for most patients.^[8]

Medications to Control Blood Pressure and Protein Loss

One of the most important medication classes used in nephrotic syndrome are drugs called angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). These medications have a dual benefit: they lower blood pressure and reduce the amount of protein that leaks from the kidneys into the urine. ACE inhibitors include medicines with active substances such as lisinopril, benazepril, captopril, and enalapril. ARBs include losartan and valsartan. These drugs work by affecting the hormones that control blood pressure and kidney filtering, making the kidney filters less “leaky” to proteins.^[8][21]

Patients typically take these medications daily for extended periods, often for as long as they have nephrotic syndrome. The treatment helps preserve kidney function over time and may allow some patients to maintain stable kidney health for years. Side effects can include dizziness, cough (more common with ACE inhibitors), and changes in blood potassium levels, which is why regular blood tests are needed to monitor kidney function and electrolyte balance.^[8]

Managing Fluid Buildup with Diuretics

Swelling is one of the most uncomfortable symptoms of nephrotic syndrome. When protein levels in the blood drop too low, fluid leaks out of blood vessels and accumulates in body tissues, causing swelling around the eyes, in the legs and ankles, and sometimes throughout the entire body. Diuretics, also known as “water pills,” help the kidneys remove excess salt and water from the body through increased urination.^[8][21]

Loop diuretics are the most commonly used type for nephrotic syndrome because they are powerful enough to overcome the kidney’s tendency to hold onto salt and water in this condition. Patients taking diuretics need to be monitored for dehydration, electrolyte imbalances (especially low potassium), and changes in kidney function. The dose is often adjusted based on how much swelling the patient has and how their body responds.^[8]

Steroid Medications for Immune System Control

For many patients, especially children with minimal change disease, corticosteroids (often simply called steroids) are the main treatment. The most commonly used steroid is prednisolone. These powerful medications work by suppressing the immune system, which can reduce inflammation in the kidneys and stop protein from leaking into the urine.^[13][14]

In children newly diagnosed with nephrotic syndrome, treatment typically begins with at least four weeks of daily prednisolone, followed by another four weeks of a lower dose taken every other day. This approach leads to remission (disappearance of protein from urine and resolution of swelling) in most children within a few weeks. Adults may also receive steroids, though the evidence for their effectiveness is less clear in adult minimal change disease.^[13][14]

While steroids can be very effective, they also cause significant side effects, especially with long-term use. Common side effects include increased appetite and weight gain, mood changes, a round or puffy appearance to the face, increased risk of infections, high blood sugar, bone thinning, and growth problems in children. Because of these side effects, doctors try to use the lowest effective dose for the shortest time possible. Many patients experience relapses where symptoms return, requiring repeated courses of steroids.^[13][14]

Other Immunosuppressive Medications

When nephrotic syndrome does not respond well to steroids, or when patients experience frequent relapses requiring repeated steroid courses, doctors may prescribe alternative immunosuppressive drugs. These include cyclophosphamide, mycophenolate mofetil, tacrolimus, cyclosporine, and levamisole. Each of these medications works differently to suppress the immune system and reduce kidney inflammation.^[13]

Calcineurin inhibitors like tacrolimus and cyclosporine are particularly important for patients with steroid-resistant nephrotic syndrome, meaning their condition does not improve with steroid treatment alone. These drugs can be effective but require careful monitoring because they can affect kidney function and have other side effects including high blood pressure, tremors, and increased hair growth. Blood tests are needed regularly to ensure drug levels stay in the therapeutic range.^[13]

Managing Complications

Nephrotic syndrome increases the risk of several serious complications that require additional preventive treatment. Blood clots can form more easily because important clotting-prevention proteins are lost in the urine and the blood becomes more concentrated. Some patients may need blood-thinning medications, though this decision is made carefully by balancing the risk of clots against the risk of bleeding. The 2021 guidelines from Kidney Disease: Improving Global Outcomes (KDIGO) suggest that the decision to use preventive anticoagulation should be individualized based on each patient’s specific risk factors.^[13]

High cholesterol and triglycerides are common in nephrotic syndrome and can be controlled with medications called statins (though rosuvastatin should be avoided as it can worsen protein loss). However, experts emphasize that the ideal approach is to treat the underlying proteinuria itself, as this addresses the root cause of the lipid abnormalities.^[13]

Infections are another major concern because antibodies that help fight infections are lost in the urine. Children may be given penicillin during relapses to reduce infection risk. Some patients receive pneumonia vaccines and other immunizations to provide additional protection.^[14]

Dietary Modifications

Diet plays an important role in managing nephrotic syndrome symptoms. Doctors typically recommend reducing salt intake to help control swelling and blood pressure. Limiting fluids may also be advised when swelling is severe. Despite the loss of protein in the urine, a high-protein diet is not recommended because it does not help replace the lost protein and may actually worsen kidney function. Instead, a moderate, kidney-friendly protein intake is suggested. Working with a dietitian who specializes in kidney disease can help patients make appropriate food choices.^[8][11]

Emerging Treatments in Clinical Research

For patients whose nephrotic syndrome does not respond well to standard treatments, or for those seeking alternatives with fewer side effects, clinical trials are investigating promising new therapies. These research studies test innovative approaches that may become standard treatments in the future.^[13]

Rituximab for Steroid-Dependent Disease

One of the most promising developments in recent years is the use of rituximab, a medication that targets a specific type of immune cell called B-cells. Rituximab was originally developed to treat certain cancers and autoimmune diseases, but clinical trials have shown it can be effective for nephrotic syndrome, particularly in patients who depend on steroids or have frequent relapses.^[13]

Rituximab works by temporarily removing B-cells from the circulation, which appears to interrupt the immune processes that damage the kidney filters. Studies have demonstrated that rituximab can help maintain remission and reduce or eliminate the need for continuous steroid therapy, thereby avoiding steroid side effects. The medication is given as an intravenous infusion in a clinic or hospital setting. Clinical trials have tested various dosing schedules to determine the most effective approach with the fewest side effects.^[13]

Phase II and Phase III trials have shown positive results in both children and adults with steroid-dependent or frequently relapsing nephrotic syndrome. Rituximab has become an established steroid-sparing option in many centers, though it continues to be studied in clinical trials to optimize its use. Side effects can include infusion reactions, increased infection risk, and rare but serious complications, so patients receiving rituximab need careful monitoring.^[13]

Apheresis Therapy for Resistant Cases

For patients with idiopathic nephrotic syndrome that fails to respond to medications, a procedure called apheresis is being studied as a potential treatment option. Apheresis involves filtering the blood through a machine that removes certain substances that may be contributing to kidney damage, similar to dialysis but with a different purpose.^[13]

A retrospective study that included 21 adult patients with focal segmental glomerulosclerosis or minimal change disease who had not responded to corticosteroids and at least one other immunosuppressive drug found that apheresis led to complete or partial remission in 7 of the 21 patients at 12 months follow-up. Factors associated with better outcomes included the need for dialysis before apheresis, age 50 years or older, a marked decrease in protein in the urine during treatment, and a shorter time between diagnosis and the apheresis procedure (less than 12 months).^[13]

This therapy represents a potential option for patients with severe, treatment-resistant disease, though more research is needed to confirm its effectiveness and to determine which patients are most likely to benefit. Apheresis requires specialized equipment and trained staff, and is typically only available at larger medical centers with experience in this procedure.^[13]

Novel Immunosuppressive Agents Under Investigation

Researchers continue to investigate new immunosuppressive medications and combinations of existing drugs to find more effective treatments with fewer side effects. Clinical trials are testing different dosing strategies, treatment durations, and combinations of medications to optimize outcomes for various types of nephrotic syndrome. These studies help determine which approaches work best for specific patient populations and disease subtypes.^[13]

Some trials are exploring prolonged or high-dose intravenous pulse corticosteroid therapy for steroid-resistant cases. Others are testing whether combining medications can achieve better results than using each drug alone. The goal is to find treatment regimens that effectively control disease while minimizing the burden of side effects that can significantly impact quality of life.^[13]

Understanding Clinical Trial Phases

Clinical trials for nephrotic syndrome treatments proceed through several phases. Phase I trials focus primarily on safety, testing new treatments in small numbers of people to determine appropriate doses and identify side effects. Phase II trials enroll more patients to evaluate whether the treatment is effective at controlling disease and to gather more information about safety. Phase III trials are large studies that compare the new treatment to current standard treatments to determine if it is better, equally effective, or has fewer side effects.^[12]

Patients considering participation in clinical trials should discuss the potential benefits and risks with their nephrologist. Trials may offer access to promising new treatments before they become widely available, but they also involve uncertainties about effectiveness and potential unknown side effects. Eligibility for trials depends on factors such as the type of nephrotic syndrome, previous treatments tried, kidney function level, and other health conditions.^[12]

Most Common Treatment Methods

• Blood Pressure Medications
  • Angiotensin-converting enzyme (ACE) inhibitors such as lisinopril, benazepril, captopril, and enalapril reduce blood pressure and protein loss in urine
  • Angiotensin II receptor blockers (ARBs) including losartan and valsartan work similarly to ACE inhibitors and are used when ACE inhibitors cause intolerable side effects like cough
  • These medications are typically taken daily for extended periods and require monitoring of kidney function and potassium levels
• Diuretics (Water Pills)
  • Loop diuretics help control swelling by increasing urination and removing excess salt and water from the body
  • Dosing is adjusted based on the amount of swelling and the body’s response
  • Patients need monitoring for dehydration and electrolyte imbalances
• Corticosteroid Therapy
  • Prednisolone is the most commonly used steroid, given daily initially then on alternate days
  • Children typically receive at least 4 weeks of daily treatment followed by 4 weeks of alternate-day dosing
  • Effective for minimal change disease but causes side effects including weight gain, mood changes, increased infection risk, and bone thinning
  • Cannot be stopped suddenly and must be tapered gradually under medical supervision
• Immunosuppressive Medications
  • Cyclophosphamide, mycophenolate mofetil, and levamisole are used for patients with frequent relapses or steroid dependence
  • Tacrolimus and cyclosporine (calcineurin inhibitors) are the principal choice for steroid-resistant nephrotic syndrome
  • These medications suppress the immune system through different mechanisms and require regular blood tests to monitor drug levels and kidney function
• Rituximab Therapy
  • An antibody medication that targets B-cells in the immune system
  • Given as an intravenous infusion, effective for steroid-dependent or frequently relapsing disease
  • Helps maintain remission and reduces or eliminates the need for continuous steroid therapy
  • Requires monitoring for infusion reactions and increased infection risk
• Lipid-Lowering Therapy
  • Statins control the high cholesterol and triglyceride levels common in nephrotic syndrome
  • Rosuvastatin should be avoided as it can worsen protein loss
  • The primary therapeutic target remains treating the underlying proteinuria
• Dietary Modifications
  • Sodium restriction helps control swelling and blood pressure
  • Fluid restriction may be necessary when swelling is severe
  • Moderate, kidney-friendly protein intake rather than high-protein diet
  • Working with a specialized kidney dietitian helps optimize nutrition
• Anticoagulation Therapy
  • Blood-thinning medications may be used for patients at high risk of blood clots
  • Decision to use preventive anticoagulation is individualized based on balancing clot risk versus bleeding risk
  • Not routinely recommended for all patients with nephrotic syndrome